Journals / Kocaeli Tıp Dergisi / 2021 / Cilt: 10 - Sayı: Ek 2

MINERAL METABOLISM AND HYPOPARATHYROIDISM IN PREGNANCY AND LACTATION

Gebelikte ve Laktasyonda Mineral Metabolizması ve Hipoparatiroidizm

Pages
194–204
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is recommended that 1-1.5 gr calcium and 0.5-3 μg calcitriol (divided doses) daily or 50000-150000 IU 25(OH) vitamin D (weekly) may be given in the treatment of maternal hypoparathyroidism.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Need of calcium, phosphorus and magnesium increases in pregnancy, but corrected calcium, ionized calcium, phosphorus or magnesium levels do not change.
📊
Key Findings & Data:Increased maternal PTHrP in pregnancy increases 1-alfa hydroxylase activity in kidney and placenta, and thus increases calcitriol synthesis.
💡
Conclusion & Impact:It is recommended that 1-1.5 gr calcium and 0.5-3 μg calcitriol (divided doses) daily or 50000-150000 IU 25(OH) vitamin D (weekly) may be given in the treatment of maternal hypoparathyroidism.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Need of calcium, phosphorus and magnesium increases in pregnancy, but corrected calcium, ionized calcium, phosphorus or magnesium levels do not change. Increased maternal PTHrP in pregnancy increases 1-alfa hydroxylase activity in kidney and placenta, and thus increases calcitriol synthesis. PTH may decrease below normal range in the first trimester of pregnancy, but increases up to mid-normal levels in the subsequent weeks. Corrected and ionized calcium levels are in normal limits in lactation. Increasing levels of PTHrP in lactation stimulates calcium resorption from maternal skeleton and calcium reabsorption from kidneys; PTH levels are measured at lower limits of normal. Because transplacental calcium entry continues at the expense of maternal skeletal resorption, fetal hypocalcemia does not occur unless severe maternal hypocalcemia emerges. Some pregnant women need less calcium replacement in the earlier pregnancy. Close follow-up is necessary when the women with hypoparathyroidism become pregnant. Maternal hypo- or hypercalcemia should be avoided in pregnancy. It is recommended that 1-1.5 gr calcium and 0.5-3 μg calcitriol (divided doses) daily or 50000-150000 IU 25(OH) vitamin D (weekly) may be given in the treatment of maternal hypoparathyroidism. In the management of maternal hypoparathyroidism during pregnancy, medical doctors in obstetrics, endocrinology and pediatrics should be collaborated with each other. Corrected serum calcium or ionized calcium levels should be adjusted as to be at lower-normal reference range in pregnancy and lactation, measured at each 3-4 weeks in pregnancy, weekly in first month of lactation, and monthly in later lactation.

Özet

Gebelikte kalsiyum, fosfor ve magnezyum ihtiyacı artar, ancak düzeltilmiş kalsiyum, iyonize kalsiyum, fosfor ve magnezyum seviyeleri değişmez. Gebelikte maternal PTHrP artarak böbrek ve plasentada 1-alfa hidroksilaz aktivitesini ve kalsitriol sentezini arttırır. Gebeliğin ilk trimesterinde PTH normalin altına düşebilir, sonraki haftalarda orta-normal aralığa yükselir. Laktasyonda düzeltilmiş kalsiyum ve iyonize kalsiyum seviyesi normal sınırlardadır. Laktasyonda PTHrP seviyesi artarak maternal iskeletten kalsiyum rezorpsiyonunu ve böbreklerden kalsiyum abzorpsiyonunu uyarır, PTH alt sınırda ölçülür. Maternal iskelet yıkımı pahasına, transplasental kalsiyum geçişi devam ettiğinden, ciddi maternal hipokalsemi gelişmedikçe fetal hipokalsemi beklenmez. Bazı gebeler erken dönemde kalsiyum replasmanına daha az ihtiyaç duyarlar. Hipoparatiroidizm tanısı olan kadınlar gebe kaldığında yakın takip gereklidir. Gebelikte maternal hipokalsemiden ve hiperkalsemiden kaçınılmalıdır. Maternal hipoparatiroidizm tedavisinde günlük 1-1,5 gram kalsiyum ve 0,5-3 μg kalsitriol (bölünmüş dozlarda) veya haftalık 50000-150000 IU 25(OH)D vitamini verilmesi önerilir. Gebelikte hipoparatiroidi izleminde obstetrik, endokrinoloji ve pediatri doktorları iş birliği içinde olmalıdır. Düzeltilmiş serum kalsiyum veya iyonize kalsiyum düzeyi gebelik boyunca 3-4 haftada bir, laktasyonda ilk ay haftalık sonra ayda bir ölçülmelidir; gebelikte ve laktasyonda alt-normal referans aralığında tutulmalıdır.

🔖

Cite This Article

TOPALOĞLU, Ö., ŞAHİN, B., ŞAHİN, İ. (2022). MINERAL METABOLISM AND HYPOPARATHYROIDISM IN PREGNANCY AND LACTATION. Kocaeli Tıp Dergisi, Cilt: 10 - Sayı: Ek 2, 194–204. https://ajindex.com/articles/574709

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Kovacs CS. Maternal Mineral and Bone Metabolism During Pregnancy, Lactation, and Post-Weaning Recovery. Physiol Rev. 2016; 96(2): 449‐547
  2. Trotter M, Hixon BB. Sequential changes in weight, density, and percentage ash weight of human skeletons from an early fetal period through old age. Anat Rec. 1974; 179: 1–18
  3. MacIsaac RJ, Heath JA, Rodda CP, Moseley JM, Care AD, Martin TJ et al. Role of the fetal parathyroid glands and parathyroid hormone-related protein in the regulation of placental transport of calcium, magnesium and inorganic phosphate. Reprod Fertil Dev. 1991; 3: 447–457
  4. Schauberger CW, Pitkin RM. Maternal-perinatal calcium relationships. Obstet Gynecol. 1979; 53: 74–76
  5. Callies F, Arlt W, Scholz HJ, Reincke M, Allolio B. Management of hypoparathyroidism during pregnancy – report of twelve cases. Eur J Endocrinol. 1998; 139: 284–289
  6. Dahlman T, Sjoberg HE, Bucht E. Calcium homeostasis in normal pregnancy and puerperium. A longitudinal study. Acta Obstet Gynecol Scand. 1994; 73: 393–398
  7. Seki K, Makimura N, Mitsui C, Hirata J, Nagata I. Calcium-regulating hormones and osteocalcin levels during pregnancy: a longitudinal study. Am J Obstet Gynecol. 1991; 164: 1248–1252
  8. Ardawi M, Nasrat HA, BA’Aqueel HS. Calcium-regulating hormones and parathyroid hormone-related peptide in normal human pregnancy and postpartum: a longitudinal study. Eur J Endocrinol. 1997; 137: 402–409
  9. Taylor RN, Badell ML. Greenspan’s Basic and Clinical Endocrinology (9th ed.), edited by Gardner DG, Shoback DG. New York: Lange Medical Books/McGraw-Hill, 2011. The endocrinology of pregnancy; p. 553-572
  10. Potts JT Jr, Bringhurst FR, Gardella T, Nussbaum S, Segre G, Kronenberg HM. Endocrinology, edited by DeGroot LJ.Philadelphia:Saunders; 1995. Parathyroid hormone: physiology, chemistry, biosynthesis, secretion, metabolism, and mode of action; p. 920–966
  11. Tsuchida T, Ishimura E, Hirowatari K, Matsumoto N, Imanishi Y, Jono S et al. Serum levels of 1–84 and 7–84 parathyroid hormone in predialysis patients with chronic renal failure measured by the intact and bio-PTH assay. Nephron Clin Pract 2006; 102(3-4): c108–114
  12. Kirby BJ, Ma Y, Martin HM, Buckle Favaro KL, Karaplis AC, Kovacs CS. Upregulation of calcitriol during pregnancy and skeletal recovery after lactation do not require parathyroid hormone. J Bone Miner Res. 2013; 28: 1987-2000
  13. Kovacs CS, Kronenberg HM. Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lac